Arecor Therapeutics plc

Arecor Therapeutics plcverified

AREC.L

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headqua...[Read more]

Industry

Biotechnology

IPO Date

2021-06-03

Stock Exchange

LSE

Ticker

AREC.L

The Current Ratio as of December 2025 (TTM) for Arecor Therapeutics plc (AREC.L) is 2.05

According to Arecor Therapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.05. This represents a change of 1.10% compared to the average of 2.03 of the last 4 quarters.

Arecor Therapeutics plc (AREC.L) Historical Current Ratio (quarterly & annually)

How has AREC.L Current Ratio performed in the past?

The mean historical Current Ratio of Arecor Therapeutics plc over the last ten years is 3.70. The current 2.05 Current Ratio has changed 5.45% with respect to the historical average. Over the past ten years (40 quarters), AREC.L's Current Ratio was at its highest in in the June 2021 quarter at 10.89. The Current Ratio was at its lowest in in the June 2024 quarter at 1.37.

Quarterly (TTM)
Annual

Average

3.70

Median

2.71

Minimum

1.85

Maximum

9.05

Arecor Therapeutics plc (AREC.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arecor Therapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 233.43%

Maximum Annual Current Ratio = 9.05

Minimum Annual Increase = -53.73%

Minimum Annual Current Ratio = 1.85

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.5316.60%
20232.17-53.73%
20224.69-48.20%
20219.05233.43%
20202.71-28.11%
20193.78-16.43%
20194.52144.60%
20181.85-6.63%

Arecor Therapeutics plc (AREC.L) Average Current Ratio

How has AREC.L Current Ratio performed in the past?

The current Current Ratio of Arecor Therapeutics plc (AREC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.13

5-year avg

4.23

10-year avg

3.70

Arecor Therapeutics plc (AREC.L) Current Ratio vs. Peers

How is AREC.L’s Current Ratio compared to its peers?

Arecor Therapeutics plc’s Current Ratio is less than Poolbeg Pharma PLC (24.94), less than Novacyt S.A. (6.33), less than Aptamer Group plc (2.44), less than Sareum Holdings plc (12.53), greater than Renalytix Plc (0.24), greater than Hemogenyx Pharmaceuticals Plc (0.72), greater than Fusion Antibodies plc (2.02), less than Genflow Biosciences plc (3.09), less than OptiBiotix Health Plc (4.61), less than IXICO plc (4.28),

Build a custom stock screener for Arecor Therapeutics plc (AREC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arecor Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arecor Therapeutics plc (AREC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arecor Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Arecor Therapeutics plc's Current Ratio?

How is the Current Ratio calculated for Arecor Therapeutics plc (AREC.L)?

What is the highest Current Ratio for Arecor Therapeutics plc (AREC.L)?

What is the 3-year average Current Ratio for Arecor Therapeutics plc (AREC.L)?

What is the 5-year average Current Ratio for Arecor Therapeutics plc (AREC.L)?

How does the current Current Ratio for Arecor Therapeutics plc (AREC.L) compare to its historical average?